Novo Nordisk | Ventes



Sales Changement Date
ANI Pharmaceuticals USD 197.1M 6.5M 2025-03
Aurora Cannabis CAD 88.2M 7.08M 2024-12
Bausch Health Companies USD 2.26B 300M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Canopy Growth CAD 74.76M 11.77M 2024-12
Corcept Therapeutics USD 157.2M 24.69M 2025-03
Drreddys Laboratories INR 83.59B 3.42B 2024-12
Eli Lilly USD 12.73B 802.8M 2025-03
GlaxoSmithKline GBP 7.52B 600M 2025-03
Merck USD 15.53B 94M 2025-03
Novartis USD 13.15B 330M 2024-12
Novo Nordisk 78.09B 7.59B 2025-03
Novo Nordisk DKK 78.09B 7.59B 2025-03
Pacira USD 168.92M 18.33M 2025-03
Perrigo USD 1.04B 98.3M 2025-03
Prestige Brands USD 296.52M 6.2M 2025-03
Sanofi EUR 9.9B 660M 2025-03
Supernus Pharmaceuticals USD 149.8M 24.36M 2025-03
Zoetis USD 2.22B 97M 2025-03



Novo Nordisk Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.